Bayer to license Cedilla’s selective inhibitors in precision oncology

By NS Healthcare Staff Writer

02 Jun 23

The license agreement provides Bayer with exclusive rights to develop and commercialise Cedilla’s CyclinE1/CDK2 inhibitors that are currently…

PharmaceuticalsPartnerships and Licensing Agreements

Fujifilm Cellular Dynamics rolls out iCell Blood-Brain Barrier Isogenic Kit

By NS Healthcare Staff Writer

02 Jun 23

Available commercially by the end of June, the iCell Blood-Brain Barrier Isogenic Kit is an off-the-shelf, ready-to-use cell…

PharmaceuticalsDrug discovery

Eikon Therapeutics buys global rights to several clinical-stage assets

By NS Healthcare Staff Writer

02 Jun 23

In addition to the transactions, Eikon has concluded the initial portion of a Series C equity financing, securing…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Pfizer secures FDA approval for RSV vaccine Abrysvo in older adults

By NS Healthcare Staff Writer

01 Jun 23

Abrysvo is a bivalent RSV prefusion F (RSVpreF) unadjuvanted vaccine that contains two preF proteins to optimise the…

PharmaceuticalsRegulation

InDex Pharmaceuticals, Viatris sign deal to commercialise cobitolimod in Japan

By NS Healthcare Staff Writer

01 Jun 23

Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

3M to invest nearly $150 million to advance capabilities in biopharma filtration technology

By NS Healthcare Staff Writer

01 Jun 23

The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing…

PharmaceuticalsBiotechnology Equipment and Materials

Artificial Intelligence System Predicts Consequences of Gene Modifications

By NS Healthcare Staff Writer

01 Jun 23

Researchers trained a computer model to understand the connections between thousands of genes—and pinpoint how those connections go…

PharmaceuticalsDrug discovery

XtalPi forges AI drug discovery collaboration worth up to $250m with Lilly

By NS Healthcare Staff Writer

31 May 23

The drug discovery partnership will make use of XtalPi’s integrated AI capabilities and robotics platform to design and…

PharmaceuticalsDrug discovery

Kiyatec, AstraZeneca partner to use KIYA-Predict for preclinical assets evaluation

By NS Healthcare Staff Writer

31 May 23

The platform enables a research strategy that uses Kiyatec's capacity to correctly dissociate and characterise primary patient tissues…

PharmaceuticalsDrug discovery

Amplia unveils positive pre-clinical data for AMP945 plus Folfirinox in pancreatic cancer

By NS Healthcare Staff Writer

30 May 23

The new data is generated from preclinical studies conducted in a laboratory at the Garvan Institute of Medical…

PharmaceuticalsClinical trials